The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,626,372 in first-year total cost, median $356,221.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-M (11)]2
- Special Emphasis Panel[ZRG1 CVRS-Q (11)]1
- Special Emphasis Panel[ZRG1 ETTN-P (13)]1
Most frequent institutions
- ALLINAIRE THERAPEUTICS, LLC1
- AMYDIS DIAGNOSTICS, INC.1
- CIRCUMVENT PHARMACEUTICALS, INC.1
- ENCEPHEAL THERAPEUTICS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Development of Novel Prion Disease Diagnostic1R43AG057421-01A1 | SARRAF, STELLA | AMYDIS DIAGNOSTICS, INC., CA | $408,225 | ZRG1 |
| 2017 | Development of a Fully Humanized Antibody for Treating Lung Emphysema2R44HL127873-03 | CLAUSS, MATTHIASHAY, DOUGLAS W.P.PETRACHE, IRINA | ALLINAIRE THERAPEUTICS, LLC, OH | $715,140 | ZRG1 |
| 2017 | Novel Modafinil Analogs as Cocaine Pharmacotherapies1U43DA043285-01A1 | CHILDERS, STEVEN R | ENCEPHEAL THERAPEUTICS, INC., NC | $304,217 | ZRG1 |
| 2017 | Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)1R43NS100233-01 | LIM, ANDREWSTEINER, ROBERT DAVIDWILEY, DEVIN THOMAS | CIRCUMVENT PHARMACEUTICALS, INC., CA | $198,790 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.